Tersi
NDC Package 23710-225-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Tersi is for the treatment of seborrheic dermatitis and tinea versicolor of the skin. Marketed by Quinnova Pharmaceuticals, Inc., this product is identified by NDC 23710-225.

Identification & Billing

NDC Package Code
23710-225-01
Package Description
10 g in 1 CANISTER
Product Code
23710-225
11-Digit Billing Format
23710022501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tersi
Dosage Form
-
Usage Information
For the treatment of seborrheic dermatitis and tinea versicolor of the skin.

Regulatory & Marketing

Labeler Name
Quinnova Pharmaceuticals, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
12-01-2009
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (23710-225). Click a package code to view its specific billing and regulatory data.

23710-225-70
70 g in 1 CANISTER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 23710-225-01 identifies a specific commercial package of 10 g in 1 canister of Tersi, labeled by Quinnova Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Quinnova Pharmaceuticals, Inc. on December 01, 2009. The current certification is valid through December 31, 2017.

How is this Quinnova Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 23710022501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
23710-225-01
11-Digit CMS (5-4-2)
23710-0225-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.